Fennec Pharmaceuticals (NASDAQ: FENC) revenue
Fennec Pharmaceuticals reported revenue of $44.6m for fiscal 2025, 6.1% less than in fiscal 2024 ($47.5m).
Fennec Pharmaceuticals's best year of the last 8 was fiscal 2024. The biggest drop was in fiscal 2025, −6.1%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $44.6m | −6.1% | −$6.3m | −14.1% |
| 2024 | $47.5m | +123.7% | $2.6m | 5.4% |
| 2023 | $21.3m | +1,101.4% | −$12.8m | −60.1% |
| 2022 | $1.8m | — | −$22.6m | −1,276.9% |
| 2019 | $0.0m | — | −$13.0m | — |
| 2018 | $0.0m | — | −$10.4m | — |
| 2017 | $0.0m | — | −$7.0m | — |
| 2016 | $0.0m | — | −$2.9m | — |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Fennec Pharmaceuticals revenue compared with its sector
By revenue for its latest fiscal year, Fennec Pharmaceuticals ranks 332nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Fennec Pharmaceuticals, −6.1%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 330th | Septerna | $46.0m | 4,174.5% |
| 331st | TriSalus Life Sciences | $45.2m | 53.4% |
| 332nd | Fennec Pharmaceuticals | $44.6m | −6.1% |
| 333rd | Aquestive Therapeutics | $44.5m | −22.6% |
| 334th | Wave Life Sciences | $42.7m | −60.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Fennec Pharmaceuticals
- How much revenue did Fennec Pharmaceuticals make in fiscal 2025?
- Fennec Pharmaceuticals reported revenue of $44.6m for fiscal 2025, compared with $47.5m in fiscal 2024.
- What was the best year for revenue at Fennec Pharmaceuticals?
- Of its last 8 fiscal years, fiscal 2024, with $47.5m.
- Where does Fennec Pharmaceuticals rank in its sector by revenue?
- It ranks 332nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Fennec Pharmaceuticals come from?
- From the annual report (Form 10-K) that Fennec Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Fennec Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2019 · 2018 · 2017 · 2016. More on Fennec Pharmaceuticals: the Fennec Pharmaceuticals page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.